Frank Kroschinsky

4.4k total citations · 1 hit paper
85 papers, 2.3k citations indexed

About

Frank Kroschinsky is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Frank Kroschinsky has authored 85 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 31 papers in Oncology and 21 papers in Genetics. Recurrent topics in Frank Kroschinsky's work include Hematopoietic Stem Cell Transplantation (26 papers), Acute Myeloid Leukemia Research (18 papers) and Lymphoma Diagnosis and Treatment (18 papers). Frank Kroschinsky is often cited by papers focused on Hematopoietic Stem Cell Transplantation (26 papers), Acute Myeloid Leukemia Research (18 papers) and Lymphoma Diagnosis and Treatment (18 papers). Frank Kroschinsky collaborates with scholars based in Germany, Switzerland and United Kingdom. Frank Kroschinsky's co-authors include Gerhard Ehninger, Martin Bornhäuser, Christian Thiede, Friedrich Stölzel, Michael Krämer, Matthias Kochanek, Simone von Bonin, Gernot Beutel, Michael Kiehl and Peter Schellongowski and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Frank Kroschinsky

82 papers receiving 2.2k citations

Hit Papers

New drugs, new toxicities: severe side effects of modern ... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management
    2017 331 citations Frank Kroschinsky, Friedrich Stölzel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Kroschinsky Germany 24 875 674 598 542 526 85 2.3k
Attilio Guarini Italy 25 533 0.6× 433 0.6× 616 1.0× 458 0.8× 135 0.3× 112 2.1k
Kevin Song Canada 26 1.4k 1.6× 565 0.8× 1.1k 1.9× 637 1.2× 180 0.3× 181 2.6k
James D. Hoyer United States 29 1.3k 1.4× 1.2k 1.8× 471 0.8× 634 1.2× 167 0.3× 121 2.8k
Anna Marina Liberati Italy 31 1.3k 1.5× 689 1.0× 1.9k 3.3× 1.3k 2.4× 397 0.8× 148 3.8k
Andrea Rubbert‐Roth Germany 33 1.5k 1.7× 885 1.3× 647 1.1× 565 1.0× 306 0.6× 123 5.1k
David T. Yang United States 33 354 0.4× 602 0.9× 768 1.3× 653 1.2× 125 0.2× 91 2.7k
Deepa Bhojwani United States 31 1.1k 1.3× 388 0.6× 957 1.6× 326 0.6× 262 0.5× 111 3.5k
Rolf Rau Germany 23 963 1.1× 394 0.6× 298 0.5× 310 0.6× 89 0.2× 39 3.3k
Yoshiyuki Kosaka Japan 26 1.3k 1.4× 261 0.4× 514 0.9× 105 0.2× 215 0.4× 146 2.6k
Hayden G. Braine United States 19 2.3k 2.6× 518 0.8× 575 1.0× 169 0.3× 200 0.4× 34 3.5k

Countries citing papers authored by Frank Kroschinsky

Since Specialization
Citations

This map shows the geographic impact of Frank Kroschinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Kroschinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Kroschinsky more than expected).

Fields of papers citing papers by Frank Kroschinsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Kroschinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Kroschinsky. The network helps show where Frank Kroschinsky may publish in the future.

Co-authorship network of co-authors of Frank Kroschinsky

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Kroschinsky. A scholar is included among the top collaborators of Frank Kroschinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Kroschinsky. Frank Kroschinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eckardt, Jan‐Niklas, Susann Winter, Katja Sockel, et al.. (2025). Image-based explainable artificial intelligence accurately identifies myelodysplastic neoplasms beyond conventional signs of dysplasia. npj Precision Oncology. 10(1). 26–26.
2.
Oelschlaegel, Uta, Susann Winter, Katja Sockel, et al.. (2024). MDS-PB13 Score - Blood based detection of aberrancies by flow cytometry in patients with suspected and confirmed Myelodysplastic Neoplasms. Leukemia. 38(2). 446–450. 1 indexed citations
3.
Sockel, Katja, Friedrich Stölzel, Christoph Röllig, et al.. (2022). Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse. SHILAP Revista de lepidopterología. 3 indexed citations
4.
Eckardt, Jan‐Niklas, Michael Krämer, Katja Sockel, et al.. (2022). Deep learning identifies Acute Promyelocytic Leukemia in bone marrow smears. BMC Cancer. 22(1). 201–201. 41 indexed citations
5.
Eckardt, Jan‐Niklas, Jan Moritz Middeke, Michael Krämer, et al.. (2021). Deep learning detects acute myeloid leukemia and predicts NPM1 mutation status from bone marrow smears. Leukemia. 36(1). 111–118. 60 indexed citations
6.
Heuschkel, Sandra, Raphael Teipel, Simone von Bonin, et al.. (2021). Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury. Cancer Chemotherapy and Pharmacology. 89(1). 41–48. 6 indexed citations
7.
Hölig, Kristina, Helmuth Schmidt, Gero Hütter, et al.. (2020). Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. Bone Marrow Transplantation. 56(3). 635–645. 11 indexed citations
8.
9.
Kochanek, Matthias, Alexander Shimabukuro‐Vornhagen, Gernot Beutel, et al.. (2019). Prävalenz von Krebspatienten auf deutschen Intensivstationen. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 115(4). 312–319. 8 indexed citations
10.
Teipel, Raphael, Uta Oelschlägel, Michael Krämer, et al.. (2018). Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor. Biology of Blood and Marrow Transplantation. 24(11). 2171–2177. 24 indexed citations
11.
Schuler, Markus K., Leopold Hentschel, Michael Krämer, et al.. (2016). Impact of Different Exercise Programs on Severe Fatigue in Patients Undergoing Anticancer Treatment—A Randomized Controlled Trial. Journal of Pain and Symptom Management. 53(1). 57–66. 32 indexed citations
12.
13.
List, Carl F., et al.. (2010). Infiltration des Knochenmarks und disseminierte intravasale Gerinnung. Der Internist. 52(3). 324–327. 1 indexed citations
14.
Pels, Hendrik, Klaus Fließbach, Axel Glasmacher, et al.. (2009). Long‐term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma. Annals of Neurology. 67(2). 182–189. 82 indexed citations
15.
Kroschinsky, Frank, Juliane Mueller, Stefan Pursche, et al.. (2007). Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas. Cancer Chemotherapy and Pharmacology. 61(5). 785–790. 10 indexed citations
16.
Kroschinsky, Frank, Katrin Friedrich, Mathias Hänel, et al.. (2003). Extramedullary blast crisis of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation mimicking aggressive, translocation t(14;18)-positive B-cell lymphoma. Annals of Hematology. 82(1). 47–52. 7 indexed citations
17.
Glasmacher, Axel, Hendrik Pels, Christoph Helmstaedter, et al.. (2001). Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: Superior results in patients younger than 60 years. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
18.
Schuler, Ulrich S., Ulf Renner, Frank Kroschinsky, et al.. (2001). Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation. British Journal of Haematology. 114(4). 944–950. 34 indexed citations
19.
Ordemann, Rainer, Ralph Naumann, G Geissler, et al.. (2000). Foscarnet - an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation?. Annals of Hematology. 79(8). 432–436. 7 indexed citations
20.
Mohr, Brigitte, Thomas Illmer, Uta Oelschlägel, et al.. (1996). Complex cytogenetic and immunophenotypic aberrations in a patient with Sezary syndrome. Cancer Genetics and Cytogenetics. 90(1). 33–36. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Attilio Guarini Breakdown of academic impact, for papers by Kevin Song Breakdown of academic impact, for papers by James D. Hoyer Breakdown of academic impact, for papers by Anna Marina Liberati Breakdown of academic impact, for papers by Andrea Rubbert‐Roth Breakdown of academic impact, for papers by David T. Yang Breakdown of academic impact, for papers by Deepa Bhojwani Breakdown of academic impact, for papers by Rolf Rau Breakdown of academic impact, for papers by Yoshiyuki Kosaka Breakdown of academic impact, for papers by Hayden G. Braine
Rankless by CCL
2026